Among them, cell-based screening with small molecule libraries of already approved drugs allowed the identification of the psychotropic drug pimozide as a potential STAT5 inhibitor in CML cells [11]. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.